LDH

You have access
Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer
MOTOHIRO FUJIWARA, RYO FUJIWARA, TETSUYA URASAKI, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA

Anticancer Research April 2022, 42 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.15685
You have access
Therapeutic Response Evaluation in Advanced Melanoma Patients Incorporating Plasma cfDNA, LDH, VEGF, PD-L1, and IFN-γ Measurements
MICHAEL I. ITA, JIANG H. WANG, CYNTHIA C. HEFFRON, DEREK G. POWER, YVONNE NOLAN, ANDRÉ TOULOUSE, CHRIS C.H. LIM, NOEL FANNING and HENRY P. REDMOND

Anticancer Research February 2022, 42 (2) 801-810; DOI: https://doi.org/10.21873/anticanres.15538
You have access
Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion
STEFANO M.M. BASSO, ALESSANDRO DEL CONTE, UMBERTO ZUCCON, SANDRO C. SULFARO, GIOVANNI FANTI, FEDERICA MAFFEIS, PAOLO UBIALI, MARIO ERMANI and FRANCO LUMACHI

Anticancer Research October 2020, 40 (10) 5877-5881; DOI: https://doi.org/10.21873/anticanres.14607
You have access
Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With De Novo Metastatic Prostate Cancer
TAKESHI KOBAYASHI, RYO NAMITOME, YU HIRATA, MASAKI SHIOTA, KENJIRO IMADA, EIJI KASHIWAGI, ARIO TAKEUCHI, JUNICHI INOKUCHI, KATSUNORI TATSUGAMI and MASATOSHI ETO

Anticancer Research June 2019, 39 (6) 3191-3195; DOI: https://doi.org/10.21873/anticanres.13457
You have access
Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival
NZINGA MACK, ELIZABETH A. MAZZIO, DAVID BAUER, HERNAN FLORES-ROZAS and KARAM F.A. SOLIMAN

Anticancer Research March 2017, 37 (3) 1205-1212;
You have access
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, ONDREJ TOPOLCAN, JAROSLAV RACEK, MARTIN SVATON, RADEK KUCERA, MAREK MINARIK, LUCIE BENESOVA, ZBYNEK BORTLICEK, RENATA CHLOUPKOVA, ALEXANDR POPRACH and TOMAS BUCHLER

Anticancer Research May 2016, 36 (5) 2459-2465;

Main menu

User menu

Search

LDH